Substitution of asparagine for aspartic acid at residue 9 (D9N) of lipoprotein lipase markedly augments risk of ischaemic heart disease in male smokers
- 1 March 2000
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 149 (1) , 75-81
- https://doi.org/10.1016/s0021-9150(99)00309-3
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosisAtherosclerosis, 1997
- A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease.Journal of Clinical Investigation, 1997
- Lipoprotein lipase gene variants and risk of coronary disease: a quantitative analysis of population-based studiesInternational Journal of Clinical and Laboratory Research, 1997
- The insulin resistance syndrome and postprandial lipid intolerance in smokersAtherosclerosis, 1997
- Triglyceride lpases and atherosclerosisCurrent Opinion in Lipidology, 1995
- A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosisNature Genetics, 1995
- A Common Variant in the Gene for Lipoprotein Lipase (Asp9→Asn)Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
- The acute influence of smoking on the endotheliumAtherosclerosis, 1992
- Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein.Proceedings of the National Academy of Sciences, 1991
- The effect of cigarette smoke, nicotine, and carbon monoxide on the permeability of the arterial wallJournal of Vascular Surgery, 1988